Ex Vivo RBC Treatment for Enhanced Immunogenicity
Application
Novel method of treatment to increase RBC immunogenicity.
Key Benefits
Short, inexpensive treatment that complements existing alloimmunization techniques.
RBC processing involves compounds approved by the FDA for human use.
Potentially elevates antibody titer against any rare RBC antigen.
Technical Summary
Several immune globulin...
Published: 7/28/2023
Contributor(s): Jeanne Hendrickson, James Zimring
|